Introduction
In multiple sclerosis (MS), great medical advances have been made, resulting in a substantial number of disease-modifying therapies (DMTs). One recent finding is that initiation of medical treatment at an early disease stage affects the progression of MS more than at a later stage. 1 Specifically, Comi et al. 2 reported that early interferon-beta (IFN-β) treatment positively influenced the rate of conversion from clinically isolated syndrome (CIS) to clinical definite MS as well as magnetic resonance imaging (MRI) measures of disease activity and lesion burden. Furthermore, post hoc analyses from the TRANSFORMS and FREEDOMS phase 3 studies showed superior efficacy of fingolimod on relapse rate and lesion load in patients who had their first symptom less than 3 years ago. 3 Despite the advances in DMT, MS is still a serious and detrimental condition with significant disease activity, impaired neurological functions, and progression of disability that requires effective adjuvant rehabilitative interventions. 4 In a number of related neurological disorders including stroke, 5 diabetic neuropathy, 6 and Parkinson's disease, 7 early initiation of rehabilitative efforts are considered crucial in optimizing the effects of the specific rehabilitation treatment. To our knowledge, no reviews or original studies focusing on early initiation of rehabilitative interventions are currently existing in MS research.
Exercise therapy is one of the most promising and well-researched rehabilitative interventions in MS, and it has numerous beneficial effects on symptoms in persons with MS. 8 Of note, a recent study furthermore provided the first data on the benefits of exercise on MRI outcomes, suggesting a potential neuroprotective and disease-modifying effect in persons with MS, 9 and such effects of exercise may add further importance to an "early treatment" approach in MS. To substantiate whether there is a lack of "early treatment" exercise studies in MS, the aim of this paper is to review the existing literature on treatment initiation of exercise therapy. Based on this review, we will discuss if there may exist an overlooked "window of opportunity" in exercise therapy of persons with MS.
MS. 8 But how and when do we tend to use exercise therapy in the treatment of MS?
Exercise therapy covers a spectrum of exercise modalities ranging from endurance training to resistance training, all of which are safe and feasible in patients with MS. 10 Despite the variety of symptoms displayed by patients with MS, a wide range of functional and health-related parameters are generally modifiable by exercise. 11 In specific, original and review studies have focused intensely on investigating the beneficial effects of exercise on fatigue, balance, walking, cognition, depressive symptoms, and quality of life. 12-15 Also, the effects of different exercise modalities and a potential dose-response relationship has been evaluated. 16 However, none of the existing reviews have focused extensively on when in the disease course exercise therapy has been applied, and a knowledge gap seems to exist for this part. A previous comprehensive literature review focusing on the effects of exercise therapy included 54 studies published until 2012, did summarize some information on the respective study populations, but did not make in-depth analyses of the timing of exercise interventions. 14 We therefore updated the review by conducting a literature search in the electronic databases MEDLINE and EMBASE. The search terms included "exercise" OR "exercise therapy" AND "multiple sclerosis," and clinical trials published from 2012 and forward were included. Pilot studies, studies reporting on the same exercise intervention as a previous article, and studies without sufficient information on disease duration in the intervention group were excluded. Figure 1 illustrates the timing of exercise initiation in the existing exercise studies providing sufficient information on disease duration. Data were taken from the previous review by Latimer-Cheung et al. 14 as well as from the current review. The mean (95% confidence interval) disease duration was calculated for each study. It is clearly shown that an uninvestigated "window of opportunity" exists both in the early stages after diagnosis, but also in the diagnostic delay from the debut symptom to the actual time of diagnosis (illustrated by the hatched area in Figure  1 ). 17 Specifically, the study with the lowest average disease duration at baseline in the intervention group included patients with a mean (standard deviation (SD)) of 4.9 (2.3) years since diagnosis. 83 Consequently, initiation of exercise therapy at an early disease stage has so far not been investigated. This is probably due to the general focus on the effects of exercise on symptoms and physical function. Hence, patients with clearly evident and manifested symptoms and functional disabilities are generally included to evaluate the positive impact of exercise. In support, 89% of the exercise therapy studies in the current review have included patients with a mean Expanded Disability Status Scale (EDSS) score of ≥3, suggesting mild to moderate disability in numerous functional systems. In some studies, certain symptoms served as inclusion criteria, where patients have to display severe levels of a particular symptom. 55, 61, 67, 80, 84 Specific guidelines on exercise therapy do exist for persons with MS, 14,16 but these only recommend exercise as a tool to manage certain MS symptoms and improve general health. This will likely contribute to a rather late introduction of exercise in clinical practice, and exercise therapy from an early time-point in the disease course is thus not a fully integrated part of MS care. 85 Consequently, patients with MS are generally still less physically active than advised when compared to healthy persons. 86 This invites an evaluation of what we know from early treatment strategies in other areas and thus a rethinking of the current use of exercise in clinical practice.
What do we know?
Currently, we have substantial knowledge about the beneficial effects of different exercise modalities in persons with MS. 13 However, one aspect that seems to have slipped the attention of researchers and clinicians in the field of exercise therapy and rehabilitation in MS is the impact of "timing."
From research on medical DMTs, it is well-known that the timing of treatment initiation is crucial for the long-term prognosis. 4, 87 The rationale underlying early medical treatment in MS is to preserve the neurological reserve of patients. Neurological reserve is generally defined by two components: brain reserve (the actual volume of the brain) and cognitive reserve (the processing abilities of the brain). 88 The neurological reserve is thus the capacity of the central nervous system (CNS) to compensate for MS-related injuries. By preservation of the neurological reserve, the critical point by which injuries to the CNS are irreversible and manifests as clinical symptoms is likely postponed. Therefore, the purpose of therapeutic strategies should be to minimize relapse rate, number and volume of lesions, and general brain atrophy. Importantly, trials have shown that different medical DMTs that are initiated at an early disease stage are capable of precisely that. 89 In particular, several studies suggest that there are a "window of opportunity" early in the disease course before irreversible neurological damage manifests, as DMTs have proven more effective in terms of reducing relapse rate, 3, 87, 90 lesion load, 3, 90, 91 brain atrophy, 87 and disability progression, 87, [90] [91] [92] [93] [94] when initiated within this window. This emphasizes that timing of treatment initiation is of great clinical importance in MS.
Although there have been no studies examining the impact of timing, recent investigations of the potential neuroprotective and disease-modifying effects of exercise may pave the way for a new and somewhat overlooked application of exercise in MS. Several animal studies have shown that exercise can delay disease-onset and attenuate disease severity in mice with Experimental Autoimmune Encephalomyelitis (EAE) -an animal model of MS -by protecting against inflammatory infiltration, demyelination, and axonal loss. [95] [96] [97] In human subjects, a recent review of exercise therapy studies reported a lower relapse rate (27% reduction) in patients involved in exercise interventions, when compared to control groups, indicating a disease-modifying effect of exercise. 10 In line Figure 1 . Overview of MS exercise studies and the overlooked "window of opportunity." with this, Tallner et al. 98 observed a trend toward a lower relapse rate in patients with MS with a high versus low Sport Index (participation in structured exercise). Finally, and most recently, the first pilot data on the benefits of exercise on MRI outcomes in persons with MS were published. In the randomized controlled cross-over study by Kjolhede et al. 9 including relapse-remitting MS patients all treated with IFN-β, 24 weeks of progressive resistance training showed a trend toward reduced brain atrophy along with indications of lesion shrinkage. Furthermore, higher absolute cortical thickness values were observed in 19 of 74 investigated cortical regions. Altogether, the results from this study are the first to suggest direct neuroprotective and disease-modifying effects following high-intense exercise on biomarkers of disease progression in MS.
Why don't we?
With the new insights into the effects of exercise therapy, along with the established consensus from medical trials in MS, that there is an "window of opportunity" early in the disease course for disease-modifying treatments, 1 why not initiate exercise therapy early in the disease course as well? Potentially already at the time of the first MS symptoms. It may be possible to postpone the conversion to clinical definite MS and furthermore to preserve the neurological reserve as well as the physical and functional reserve of patients even better than by the existing medical DMTs alone. Initiation of exercise therapy before irreversible neuronal damage and degeneration occurs may ultimately reduce the manifestation and progression of disabilities further. This novel concept is presented in Figure 2 Early initiation of exercise therapy is a specific example, but the concept may hold even greater perspectives. Some symptoms and functional deficits are present already in the early stages of MS (e.g. fatigue, 88 walking, 99 cognition 100 ), and early implementation of exercise therapy as well as other rehabilitative strategies may reduce or even postpone these impairments. As such, this concept may apply to a broader field of rehabilitative interventions in MS.
If early rehabilitation can postpone functional and neurological impairments in addition to DMTs, this is of great interest to the individual MS patient, yet also to the health care system. A recent report on the costs of MS in Europe revealed that medical DMTs represent the majority of health care costs for patients with mild MS. 101 Early implementation of exercise therapy and other rehabilitory interventions may be a costeffective adjuvant strategy to reduce disability progression and the huge costs associated with this even further. Also, early rehabilitory interventions may improve the general health of the patients and thereby reduce the increased risk of lifestyle-related comorbidities to a greater extent. 102 
Conclusion
Medical trials imply that there is a "window of opportunity" early in the disease course of MS, where disease-modifying treatment is particularly effective. A review of exercise therapy studies reveal that exercise predominantly serve as symptomatic treatment and therefore is initiated at a rather late disease stage in MS, leaving the early "window of opportunity" largely uninvestigated. At the same time, recent studies have shown that exercise holds the potential to protect against neurodegeneration and to modify the disease course. On this basis, studies investigating exercise therapy as an adjuvant treatment strategy in the early stages of MS are highly warranted. This novel concept, exemplified by exercise therapy, may hold the potential to be applied in a broader MS rehabilitation context, and if proven effective, it would be of significant value to the individual MS patients (i.e. quality of life), as well as to the health care system (i.e. cost-effective).
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